What is the role of Wellbutrin (bupropion) in smoking cessation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Bupropion (Wellbutrin) for Smoking Cessation

Bupropion is an effective first-line pharmacotherapy for smoking cessation, with clinical trials showing it helps approximately one in five smokers successfully quit smoking. 1

Mechanism and Efficacy

  • Bupropion works primarily through inhibition of dopamine reuptake into neuronal synaptic vesicles and is also a weak noradrenaline reuptake inhibitor 1
  • The sustained-release (SR) formulation is specifically approved for smoking cessation under the brand name Zyban 2
  • Unique features of bupropion for smoking cessation:
    • Requires prescription, bringing smoking cessation treatment back to medical settings
    • Treatment begins 1-2 weeks before the target quit date 3
    • Non-nicotine based option for those who cannot or prefer not to use nicotine replacement therapy

Dosing and Administration

  • Start with lower doses (150 mg once daily) for 3 days, then increase to 150 mg twice daily 4
  • Maximum dose should not exceed 300 mg daily for smoking cessation
  • Administer the second dose before 3 p.m. to minimize insomnia risk 4
  • Continue treatment for 7-12 weeks after the quit date

Patient Selection

Good Candidates:

  • Smokers motivated to quit
  • Those who have failed nicotine replacement therapy
  • Patients with depression history (bupropion has shown efficacy regardless of depression history) 5
  • Those concerned about weight gain during smoking cessation 2

Contraindications:

  • Seizure disorders or conditions that lower seizure threshold 6
  • Current use of MAO inhibitors 4
  • History of anorexia or bulimia 6
  • Abrupt discontinuation of alcohol, benzodiazepines, or barbiturates 6
  • Uncontrolled hypertension 4
  • Severe hepatic impairment 4

Monitoring and Safety

  • Regular blood pressure monitoring is essential, especially during the first 12 weeks of treatment 4, 6
  • Higher incidence of treatment-emergent hypertension when combined with nicotine replacement therapy (6.1% vs. 2.5% with bupropion alone) 6
  • Risk of seizures (approximately 0.1% or 1/1000 patients) 6, 2
  • Monitor for neuropsychiatric symptoms, particularly in younger patients 4

Common Side Effects

  • Insomnia (most common)
  • Dry mouth
  • Anxiety/jitteriness
  • Decreased appetite
  • Headache 4, 1

Special Populations

Patients with Depression:

  • Bupropion is effective for smoking cessation regardless of depression history 5
  • May be particularly beneficial for smokers with current or past depression 5
  • Can be safely added to SSRI treatment for patients with depression who want to quit smoking 7

Patients with Medical Conditions:

  • Effective in patients with chronic obstructive pulmonary disease (COPD) 2
  • Use with caution in patients with cardiovascular disease; monitor blood pressure closely 6
  • Reduce dose by 50% in patients with moderate to severe renal impairment 4

Comparative Effectiveness

  • Bupropion has shown similar or superior efficacy compared to nicotine replacement therapy in some studies 2
  • Can be used in combination with nicotine patches for potentially greater efficacy, though with increased risk of hypertension 6

Practical Considerations

  • Gradual tapering is recommended when discontinuing bupropion to minimize withdrawal symptoms 4
  • Treatment duration of 7-12 weeks is standard, with longer durations potentially preventing relapse
  • Cost-effectiveness has been demonstrated in various healthcare settings 3, 2

References

Research

The use of bupropion SR in cigarette smoking cessation.

International journal of chronic obstructive pulmonary disease, 2008

Research

Review of bupropion for smoking cessation.

Drug and alcohol review, 2003

Guideline

Bupropion Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism.

The British journal of psychiatry : the journal of mental science, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.